Subscribe to RSS Feed

Prostate Cancer Tests May Prove Risky for Some Patients

NEW YORK, NY--(Marketwired - Apr 23, 2014) New evidence suggest that men who postpone prostate cancer treatment in favor of the active surveillance strategy may not have all the facts. A Cambridge University study found that as many as half of all men with prostate cancer receive an underestimated diagnosis about the severity of their disease. As a result, many men who believe they have less aggressive prostate cancer tumors may be putting themselves at risk for disease spread by postponing prostate cancer treatment.

Prostate cancer is often considered to be a slow growing, less threatening form of cancer. As such, many men decline definitive treatments such as robotic prostatectomy surgery or radiation. Instead, they participate in ongoing prostate cancer testing to monitor disease progression, opting to treat their cancer only when tests suggest it necessary. New York's David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, expressed concern about the implications of the new findings for men who postpone treatment.

"The effectiveness of active surveillance depends wholly on frequent disease assessment," said Dr. Samadi. "Without complete confidence in the results of prostate cancer tests, postponing treatment is a risky proposition," said Dr. Samadi.

The findings, published in the British Journal of Cancer, included a total of 800 prostate cancer patients who chose to have their cancer surgically removed. More than half of the 415 men who were originally diagnosed with slow-growing prostate cancer later learned they had more aggressive disease,

Further, 30 percent of the cases diagnosed as localized had actually spread outside of the prostate gland. Had these men postponed treatment, they might have missed the window for curative treatment.

"We've known for a long time that post-surgery tumor analysis is far more accurate that pre-surgery screenings," said Dr. Samadi. "Today's testing limitations can severely jeopardize the active surveillance approach. Results are simply not definitive until we see the prostate firsthand, remove all evidence of cancer, and conduct thorough lab testing."

Only 24 percent of the study participants received confirmation of low risk disease from post-surgery analysis.
Despite the range of tools used to detect and diagnose prostate cancer, neither the prostate-specific antigen (PSA) blood test, the digital rectal exam (DRE), nor the prostate biopsy are without imperfections.

"Treatment decisions must be made as a collaboration between patient and prostate cancer experts, with constant acknowledgement of how limited our understanding is before surgery," added Dr. Samadi.

As a leading robotic prostate surgery, Dr. Samadi has performed more than 5,600 successful robotic prostate surgeries to date.

Back to Press Releases

Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:


Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.

Anastasios P, Greece

Αφού διαγνώστηκα με καρκίνο του προστάτη στην Αθήνα όπως ηταν αναμενόμενο ανησύχησα πολύ.  Αφού ρώτησα τριγύρω άκουσα πως ο Δρ. Σαμάντι θα ήταν η καλύτερη επιλογή.  Πολύ φίλοι τον συνέστησαν και η εμειρία τους ήταν άριστη.

I. K.,New York

"I am very grateful to Doctor Samadi, because he promised to do everything possible to cure me and bring me back to the way I was and he did just that. I’m back to normal and enjoying my life..."

Martin K., Patchogue, NY

I was diagnosed with prostate cancer in January of 2014. After researching for a surgeon the name Dr. David Samadi kept coming up for his expertise and great results. I got an appointment and went in to see Dr. Samadi and was already convinced (from what I read) that I wanted my prostate removed.

R. H., New York, USA

"I am now a witness to the potential for change that digital technology can make in the medical industry in the hands of artists like Dr. Samadi.  The potential is Amazing!"